Locations
Vancouver, BC, Canada · North Vancouver, BC, Canada
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2021
Abdera Therapeutics is a precision oncology company focused on developing next-generation targeted radiation therapies. Utilizing their proprietary ROVEr™ platform, they aim to deliver radioisotopes that selectively destroy tumor cells while sparing healthy cells. The company is building a pipeline of innovative radiotherapeutics targeting various solid tumors, with plans to initiate Phase 1 clinical trials for small cell lung cancer and large cell neuroendocrine carcinoma. Abdera's unique approach and advanced technology position it as a leader in the rapidly evolving field of radiotherapeutics, addressing significant unmet needs in cancer treatment.
Something looks off?On-site & Remote